PrEP could complement established HIV prevention strategies for pregnant and breastfeeding women as part of a comprehensive package to reduce HIV infections among women and transmission from mothers to infants in settings with high HIV incidence.
This technical brief seeks to:
- Summarise existing data on safety and efficacy for the use of oral PrEP in pregnant and breastfeeding women, as well as women who conceive while taking PrEP.
- Describe the rationale for offering PrEP as part of a comprehensive HIV prevention package that is integrated with PMTCT, antenatal and postnatal care programmes in settings of high HIV incidence.
- Discuss considerations for offering PrEP for safer conception.
- Outline a framework to strengthen HIV prevention during the antenatal and postnatal period for mothers, their partners and infants.